Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Antigen recognition by antibody C836 through adjustment of V(L)/V(H) packingAlexey Teplyakov, Galina Obmolova, Thomas Malia, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
The molecular basis of leukemiaD Gary Gilliland, Craig T Jordan, Carolyn A Felix
Best Practice & Research. Clinical Haematology|June 20, 2006
Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapyJason Gotlib, N C P Cross, D Gary Gilliland
Journal of Visualized Experiments : Jove|December 11, 2008
Isolation of early hematopoietic stem cells from murine yolk sac and AGMKelly Morgan, Michael Kharas, Elaine Dzierzak, et al.
Seminars in Oncology|June 4, 2004
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndromeRichard M Stone, D Gary Gilliland, Amy D Klion
Blood|May 5, 2005
Drug therapy for acute myeloid leukemiaMartin S Tallman, D Gary Gilliland, Jacob M Rowe
Blood|April 30, 2009
The leukemic stem cell niche: current concepts and therapeutic opportunitiesSteven W Lane, David T Scadden, D Gary Gilliland
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A progenitor cell origin of myeloid malignanciesHiroshi Haeno, Ross L Levine, D Gary Gilliland, et al.
Nature Reviews. Cancer|August 28, 2007
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disordersRoss L Levine, Animesh Pardanani, Ayalew Tefferi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Genetics of myeloid malignancies: pathogenetic and clinical implicationsStefan Fröhling, Claudia Scholl, D Gary Gilliland, et al.
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Antigen recognition by antibody C836 through adjustment of V(L)/V(H) packingAlexey Teplyakov, Galina Obmolova, Thomas Malia, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2004
The molecular basis of leukemiaD Gary Gilliland, Craig T Jordan, Carolyn A Felix
Best Practice & Research. Clinical Haematology|June 20, 2006
Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapyJason Gotlib, N C P Cross, D Gary Gilliland
Journal of Visualized Experiments : Jove|December 11, 2008
Isolation of early hematopoietic stem cells from murine yolk sac and AGMKelly Morgan, Michael Kharas, Elaine Dzierzak, et al.
Seminars in Oncology|June 4, 2004
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndromeRichard M Stone, D Gary Gilliland, Amy D Klion
Blood|May 5, 2005
Drug therapy for acute myeloid leukemiaMartin S Tallman, D Gary Gilliland, Jacob M Rowe
Blood|April 30, 2009
The leukemic stem cell niche: current concepts and therapeutic opportunitiesSteven W Lane, David T Scadden, D Gary Gilliland
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
A progenitor cell origin of myeloid malignanciesHiroshi Haeno, Ross L Levine, D Gary Gilliland, et al.
Nature Reviews. Cancer|August 28, 2007
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disordersRoss L Levine, Animesh Pardanani, Ayalew Tefferi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Genetics of myeloid malignancies: pathogenetic and clinical implicationsStefan Fröhling, Claudia Scholl, D Gary Gilliland, et al.
Pageof 19